Drugs / CD133+ cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01198080 | Aug 2009 → Jun 2013 | osteonecrosis | Royan Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD133+ cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01198080 ↗ |
| Modality | Cell therapy | “Another treatment is utilization of bone marrow derived stem cells” NCT01198080 ↗ |
| Route | Other | “CD133+cell infusion into the cored area” NCT01198080 ↗ |